Sort
25,944 grants matching “neurodegeneration”
Subconcussive neurodegenerative progression in adolescent athletes
$574,980Keisuke Kawata · Trustees Of Indiana University · R01 · FY2024 · NS
Faculty recruitment for programs in the biology of age-related cognitive change
$574,979Bradley T Hyman · Massachusetts General Hospital · P30 · FY2009 · AG
Stress Granules and the Biology of TDP-43
$574,627Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2014 · ES
Prevention of complement and immune-mediated Lewy body dementia
$574,594Ole Isacson · Mclean Hospital · R01 · FY2020 · AG
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers
$574,583David R Hessl · University Of California At Davis · R01 · FY2016 · MH
Notch Signaling in the Adult, Aging and Diseased Brain
$574,526Yale University · R01 · FY2002 · AG
Self-assembling Nanofiber Vaccines for Neurodegeneration
$574,474Jai Rudra · Washington University · R01 · FY2024 · AG
Reprogramming proinflammatory microglia by restoring mitochondrial function
$574,023Brian M Polster · University Of Maryland Baltimore · R01 · FY2020 · NS
A Systems Approach to Stress Biology and Proteostasis Networks
$573,854Richard I. Morimoto · Northwestern University · R01 · FY2010 · GM
Axonal Pathology and TBI-Related Neurodegeneration (TReND)
$573,787Douglas Hamilton Smith · University Of Pennsylvania · R01 · FY2024 · NS
Effect of APOE on CNS Neurons: Role of LRP
$573,611David M Holtzman · Washington University · R01 · FY2018 · NS
Molecular Markers of Cerebrovascular Pathologies in Alzheimer's Disease and Related Dementias
$573,533Andre Obenaus · University Of California Riverside · R01 · FY2025 · NS
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers
$573,506David R Hessl · University Of California At Davis · R01 · FY2014 · MH
Allosteric regulation of SIRT1 by a PACS-2 and DBC1 regulatory hub
$573,246Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Core B: The Clinical and Translational Research Core
$573,107Xue K Zhong · Cleveland Clinic Foundation · P20 · FY2015 · GM
Reversing tauopathy by inhibiting MSUT2 RNA-binding activity
$573,037Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R56 · FY2019 · AG
Molecular mechanisms underlying the preservation of neural stem cell quiescence during aging
$572,715Ashley E Webb · Buck Institute For Research On Aging · R01 · FY2025 · AG
Development of selective amyloid-responsive fluorescent probes
$572,646Jerry Yang · University Of California, San Diego · R01 · FY2025 · AG
Project 3: Inhibition of L1 to Alleviate Alzheimer's Disease Pathogenosis in Mouse Models
$572,590Vera Gorbunova · Brown University · P01 · FY2022 · AG
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$572,372John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution
$572,243James A Wells · University Of California, San Francisco · R35 · FY2024 · GM
Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution
$572,243James A Wells · University Of California, San Francisco · R35 · FY2025 · GM
Surfaceomic technologies and antibodies to probe cell surface proteomes and their interactomes at unprecedented small scale and high-resolution
$572,243James A Wells · University Of California, San Francisco · R35 · FY2023 · GM
The Hypothalamic Basis of Aging
$572,233Dongsheng Cai · Albert Einstein College Of Medicine · R01 · FY2023 · AG
Molecular mechanisms of ARF family GTPases
$572,092Richard A. Kahn · Emory University · R35 · FY2022 · GM